Status: current, Not sufficiently defined by necessary conditions definition status. Date: 07-Jan 2015. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 88804601000001119 | Aclidinium bromide + Formoterol (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 88804701000001112 | Aclidinium bromide + Formoterol | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Aclidinium bromide + Formoterol | Is a | Virtual therapeutic moiety | true | Inferred relationship | Existential restriction modifier | ||
| Aclidinium bromide + Formoterol | Is a | Aclidinium bromide | true | Inferred relationship | Existential restriction modifier | ||
| Aclidinium bromide + Formoterol | Is a | Product containing formoterol | false | Inferred relationship | Existential restriction modifier | ||
| Aclidinium bromide + Formoterol | Has active ingredient | Formoterol | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Aclidinium bromide 396micrograms/dose / Formoterol 11.8micrograms/dose dry powder inhaler | Is a | True | Aclidinium bromide + Formoterol | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR